HBW
UTHR icon

Hazlett, Burt & Watson’s United Therapeutics UTHR Stock Holding History

Hazlett, Burt & Watson’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Hold
200
– – 0.04% 317
2025
Q4 		$97K Hold
200
– – 0.03% 349
2025
Q3 		$84K Hold
200
– – 0.03% 341
2025
Q2 		$57K Hold
200
– – 0.02% 357
2025
Q1 		$62K Hold
200
– – 0.03% 330
2024
Q4 		$71K Hold
200
– – 0.03% 317
2024
Q3 		$72K Hold
200
– – 0.03% 305
2024
Q2 		$64K Hold
200
– – 0.03% 306
2024
Q1 		$46K Sell
200
-21
-10% -$4.74K 0.03% 337
2023
Q4 		$49K Sell
221
-27
-11% -$6.22K 0.03% 310
2023
Q3 		$56K Hold
248
– – 0.04% 286
2023
Q2 		$55K Buy
248
+48
+24% +$10.6K 0.04% 287
2023
Q1 		$45K Hold
200
– – 0.04% 294
2022
Q4 		$56K Buy
+200
New +$50.5K 0.05% 257

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return